Viewing Study NCT01563302


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-22 @ 5:19 AM
Study NCT ID: NCT01563302
Status: COMPLETED
Last Update Posted: 2018-06-25
First Post: 2012-02-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers
Sponsor: Ionis Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module